Migraine as a systemic vasculopathy

Cephalalgia

Volumn 29, Issue 9, 2009, Pages 987-996

  Tietjen, G E ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Cardiovascular; Endothelial dysfunction; Migraine; Retinopathy; Vasculopathy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; MIGRAINE; PROPHYLAXIS; REVIEW; RISK FACTOR; VASCULAR DISEASE; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ENDOTHELIUM, VASCULAR; HUMANS; MIGRAINE DISORDERS; VASCULAR DISEASES;

EID: 68249108138     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2009.01937.x     Document Type: Review

References (98)

1. Moskowitz MA. Pathophysiology of headache - past and present. Headache 2007 47 (Suppl. 1 S58 S63.
2. Leao APP. Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944 7 : 359 90.
3. Woods RP, Iacoboni M, Mazziotta JC. Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994 331 : 1689 92.
4. Cao Y, Welch KM, Aurora S, Vikingstad EM. Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch Neurol 1999 56 : 548 54.
5. Friberg L, Olesen J, Lassen NA, Olsen TS, Karle A. Cerebral oxygen extraction, oxygen consumption, and regional cerebral blood flow during the aura phase of migraine. Stroke 1994 25 : 974 9.
6. Cutrer FM, Sorensen AG, Weisskoff RM, Ostergaard L, Sanchez DR, Lee EJ et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol 1998 43 : 25 31.
7. Collaborative Group for the Study of Stroke in Young Women. Oral contraceptives and stroke in young women. Associated risk factors. JAMA 1975 231 : 718 22.
8. Tzourio C, Iglesias S, Hubert JB, Visy JM, Alperovitch A, Tehindrazanarivelo A et al. Migraine and risk of ischaemic stroke: a case-control study. BMJ 1993 307 : 289 92.
9. Buring JE, Hebert P, Romero J, Kittross A, Cook N, Manson J et al. Migraine and subsequent risk of stroke in the physicians' health study. Arch Neurol 1995 52 : 129 34.
10. Tzourio C, Tehindrazanarivelo A, Iglesias S, Alperovitch A, Chedru F, d'Anglejan-Chatillon J et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 1995 310 : 830 3.
11. Carolei A, Marini C, De Matteis G. History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. Lancet 1996 347 : 1503 6.
12. Merikangas KR, Fenton BT, Cheng SH, Stolar MJ, Risch N. Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol 1997 54 : 362 8.
13. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA. 2006 296 : 283 91.
14. Stang PE, Carson AP, Rose KM, Mo J, Ephross SA, Shahar E et al. Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology 2005 64 : 1573 7.
15. Kurth T, Schurks M, Logroscino G, Gaziano JM, Buring JE. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ 2008 337 : a636.
16. Kurth T, Gaziano JM, Cook NR, Bubes V, Logroscino G, Diener HC et al. Migraine and risk of cardiovascular disease in men. Arch Intern Med 2007 167 : 795 801. (Pubitemid 46658337)
17. De Benedittis G, Lorenzetti A, Sina C, Bernasconi V. Magnetic resonance imaging in migraine and tension-type headache. Headache 1995 35 : 264 8.
18. Igarashi H, Sakai F, Kan S, Okada J, Tazaki Y. Magnetic resonance imaging of the brain in patients with migraine. Cephalalgia 1991 11 : 69 74.
19. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004 291 : 427 34.
20. Rose KM, Carson AP, Sanford CP, Stang PE, Brown CA, Folsom AR et al. Migraine and other headaches: associations with Rose angina and coronary heart disease. Neurology 2004 63 : 2233 9.
21. Rose KM, Wong TY, Carson AP, Couper DJ, Klein R, Sharrett AR. Migraine and retinal microvascular abnormalities: the Atherosclerosis Risk in Communities Study. Neurology 2007 68 : 1694 700.
22. Tietjen GE, Al Qasmi MM, Shukairy MS. Livedo reticularis and migraine: a marker for stroke risk? Headache 2002 42 : 352 5.
23. Tietjen GE, Gottwald L, Al Qasmi MM, Gunda P, Khuder SA. Migraine is associated with livedo reticularis: a prospective study. Headache 2002 42 : 263 7.
24. Tietjen GE, Al Qasmi MM, Gunda P, Herial NA. Sneddon's syndrome: another migraine-stroke association? Cephalalgia 2006 26 : 225 32.
25. O'Keeffe ST, Tsapatsaris NP, Beetham WP Jr. Association between Raynaud's phenomenon and migraine in a random population of hospital employees. J Rheumatol 1993 20 : 1187 8.
26. Adeney KL, Williams MA. Migraine headaches and preeclampsia: an epidemiologic review. Headache 2006 46 : 794 803.
27. Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993 22 (Suppl. 4 S1 14.
28. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003 23 : 168 75.
29. Ciancarelli I, Tozzi-Ciancarelli MG, Di Massimo C, Marini C, Carolei A. Urinary nitric oxide metabolites and lipid peroxidation by-products in migraine. Cephalalgia 2003 23 : 39 42.
30. Lang D. Cardiac hypertrophy and oxidative stress: a leap of faith or stark reality? Heart 2002 87 : 316 7.
31. Crassard I, Conard J, Bousser MG. Migraine and haemostasis. Cephalalgia 2001 21 : 630 6.
32. Hering-Hanit R, Friedman Z, Schlesinger I, Ellis M. Evidence for activation of the coagulation system in migraine with aura. Cephalalgia 2001 21 : 137 9.
33. D'Andrea G, Toldo M, Cortelazzo S, Milone FF. Platelet activity in migraine. Headache 1982 22 : 207 12.
34. Tietjen GE, Al Qasmi MM, Athanas K, Dafer RM, Khuder SA. Increased von Willebrand factor in migraine. Neurology 2001 57 : 334 6.
35. Tietjen GE, Al Qasmi MM, Athanas K, Utley C, Herial NA. Altered hemostasis in migraineurs studied with a dynamic flow system. Thromb Res 2007 119 : 217 22.
36. Blann AD. Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years. Thromb Haemost 2006 95 : 49 55.
37. Bongers TN, de Maat MP, van Goor ML, Bhagwanbali V, van Vliet HH, Gomez Garcia EB et al. High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability. Stroke 2006 37 : 2672 7.
38. Spencer CG, Felmeden DC, Blann AD, Lip GY. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. J Intern Med 2007 261 : 82 90.
39. Qizilbash N, Duffy S, Prentice CR, Boothby M, Warlow C. Von Willebrand factor and risk of ischemic stroke. Neurology 1997 49 : 1552 6.
40. Folsom AR, Rosamond WD, Shahar E, Cooper LS, Aleksic N, Nieto FJ et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 1999 100 : 736 42.
41. Bianchi A, Pitari G, Amenta V, Giuliano F, Gallina M, Costa R et al. Endothelial, haemostatic and haemorheological modifications in migraineurs. Artery 1996 22 : 93 100.
42. Macko RF, Kittner SJ, Epstein A, Cox DK, Wozniak MA, Wityk RJ et al. Elevated tissue plasminogen activator antigen and stroke risk: the stroke prevention in young women study. Stroke 1999 30 : 7 11.
43. Welch KM, Brandes AW, Salerno L, Brandes JL. C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache 2006 46 : 197 9.
44. Vanmolkot FH, de Hoon JN. Increased C-reactive protein in young adult patients with migraine. Cephalalgia 2007 27 : 843 6.
45. Kurth T, Ridker PM, Buring JE. Migraine and biomarkers of cardiovascular disease in women. Cephalalgia 2008 28 : 49 56.
46. Kaplan RC, McGinn AP, Baird AE, Hendrix SL, Kooperberg C, Lynch J et al. Inflammation and hemostasis biomarkers for predicting stroke in postmenopausal women: the Women's Health Initiative Observational Study. J Stroke Cerebrovasc Dis 2008 17 : 344 55.
47. Lee ST, Chu K, Jung KH, Kim DH, Kim EH, Choe VN et al. Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology 2008 70 : 1510 7.
48. Totaro R, Marini C, De Matteis G, Di Napoli M, Carolei A. Cerebrovascular reactivity in migraine during headache-free intervals. Cephalalgia 1997 17 : 191 4.
49. Silvestrini M, Baruffaldi R, Bartolini M, Vernieri F, Lanciotti C, Matteis M et al. Basilar and middle cerebral artery reactivity in patients with migraine. Headache 2004 44 : 29 34.
50. Kastrup A, Thomas C, Hartmann C, Schabet M. Cerebral blood flow and CO2 reactivity in interictal migraineurs: a transcranial Doppler study. Headache 1998 38 : 608 13.
51. Fiermonte G, Annulli A, Pierelli F. Transcranial Doppler evaluation of cerebral hemodynamics in migraineurs during prophylactic treatment with flunarizine. Cephalalgia 1999 19 : 492 6.
52. Sakai F, Meyer JS. Abnormal cerebrovascular reactivity in patients with migraine and cluster headache. Headache 1979 19 : 257 66.
53. Akin A, Bilensoy D. Cerebrovascular reactivity to hypercapnia in migraine patients measured with near-infrared spectroscopy. Brain Res 2006 1107 : 206 14.
54. Vernieri F, Tibuzzi F, Pasqualetti P, Altamura C, Palazzo P, Rossini PM et al. Increased cerebral vasomotor reactivity in migraine with aura: an autoregulation disorder? A transcranial Doppler and near-infrared spectroscopy study. Cephalalgia 2008 28 : 689 95.
55. de Hoon JN, Willigers JM, Troost J, Struijker-Boudier HA, van Bortel LM. Cranial and peripheral interictal vascular changes in migraine patients. Cephalalgia 2003 23 : 96 104.
56. Vanmolkot FH, van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology 2007 68 : 1563 70.
57. Gomi S, Gotoh F, Komatsumoto S, Ishikawa Y, Araki N, Hamada J. Sweating function and retinal vasomotor reactivity in migraine. Cephalalgia 1989 9 : 179 85.
58. Edvinsson ML, Edvinsson L. Comparison of CGRP and NO responses in the human peripheral microcirculation of migraine and control subjects. Cephalalgia 2008 28 : 563 6.
59. Tzourio C, El Amrani M, Poirier O, Nicaud V, Bousser MG, Alperovitch A. Association between migraine and endothelin type A receptor (ETA -231 A/G) gene polymorphism. Neurology 2001 56 : 1273 7.
60. Kario K, Matsuo T, Kobayashi H, Kanai N, Hoshide S, Mitsuhashi T et al. Endothelial cell damage and angiotensin-converting enzyme insertion/deletion genotype in elderly hypertensive patients. J Am Coll Cardiol 1998 32 : 444 50.
61. Butler R, Morris AD, Burchell B, Struthers ADD. D angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. Hypertension 1999 33 : 1164 8.
62. Makris TK, Stavroulakis GA, Dafni UG, Gialeraki AE, Krespi PG, Hatzizacharias AN et al. ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension. Am Heart J 2000 140 : 760 5.
63. von Depka M, Czwalinna A, Wermes C, Eisert R, Scharrer I, Ganser A et al. The deletion polymorphism in the angiotensin-converting enzyme gene is a moderate risk factor for venous thromboembolism. Thromb Haemost 2003 89 : 847 52.
64. Margaglione M, Celentano E, Grandone E, Vecchione G, Cappucci G, Giuliani N et al. Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke. Arterioscler Thromb Vasc Biol 1996 16 : 304 9.
65. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995 332 : 706 11.
66. Sharma P. Meta-analysis of the ACE gene in ischaemic stroke. J Neurol Neurosurg Psychiatry 1998 64 : 227 30.
67. Holmer SR, Bickeboller H, Hengstenberg C, Rohlmann F, Engel S, Lowel H et al. Angiotensin converting enzyme gene polymorphism and myocardial infarction: a large association and linkage study. Int J Biochem Cell Biol 2003 35 : 955 62.
68. Zhang JH, Kohara K, Yamamoto Y, Nakura J, Tabara Y, Fujisawa M et al. Genetic predisposition to neurological symptoms in lacunar infarction. Cerebrovasc Dis 2004 17 : 273 9.
69. Markus HS, Barley J, Lunt R, Bland JM, Jeffery S, Carter ND et al. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke 1995 26 : 1329 33.
70. Hassan A, Hunt BJ, O'Sullivan M, Parmar K, Bamford JM, Briley D et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003 126 : 424 32.
71. Purandare N, Oude Voshaar RC, Davidson Y, Gibbons L, Hardicre J, Byrne J et al. Deletion/insertion polymorphism of the angiotensin-converting enzyme gene and white matter hyperintensities in dementia: a pilot study. J Am Geriatr Soc 2006 54 : 1395 400.
72. Kowa H, Fusayasu E, Ijiri T, Ishizaki K, Yasui K, Nakaso K et al. Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura. Neurosci Lett 2005 374 : 129 31.
73. Paterna S, Di Pasquale P, D'Angelo A, Seidita G, Tuttolomondo A, Cardinale A et al. Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol 2000 43 : 133 6.
74. Schurks M, Zee RY, Buring JE, Kurth T. ACE D/I polymorphism, migraine, and cardiovascular disease in women. Neurology 2009 72 : 650 6.
75. Hassan A, Hunt BJ, O'Sullivan M, Bell R, D'Souza R, Jeffery S et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004 127 : 212 9.
76. Cronin S, Furie KL, Kelly PJ. Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis. Stroke 2005 36 : 1581 7.
77. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000 96 : 762 4.
78. Scher AI, Terwindt GM, Verschuren WM, Kruit MC, Blom HJ, Kowa H et al. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol 2006 59 : 372 5.
79. Schurks M, Zee RY, Buring JE, Kurth T. Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease. Neurology 2008 71 : 505 13.
80. Lea RA, Ovcaric M, Sundholm J, Solyom L, Macmillan J, Griffiths LR. Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility. Brain Res Mol Brain Res 2005 136 : 112 7.
81. Tietjen GE, Joe B, Herial NA, Utley C, White L, Yerga-Woolwine S. Markers of endothelial dysfunction in healthy female migraineurs. Von Willebrand factor and the ACE-DD genotype. Headache 2007 47 : 743 (Abstract).
82. Tietjen GE, Joe B, Herial NA, Utley C, White L, Yerga-Woolwine S. Genetic risk for endothelial dysfunction in women with migraine. Headache 2008 48 : S53 (Abstract).
83. Borroni B, Rao R, Liberini P, Venturelli E, Cossandi M, Archetti S et al. Endothelial nitric oxide synthase (Glu298Asp) polymorphism is an independent risk factor for migraine with aura. Headache 2006 46 : 1575 9.
84. Szolnoki Z, Havasi V, Bene J, Komlosi K, Szoke D, Somogyvari F et al. Endothelial nitric oxide synthase gene interactions and the risk of ischaemic stroke. Acta Neurol Scand 2005 111 : 29 33.
85. Cesar JM, Garcia-Avello A, Vecino AM, Sastre JL, Alvarez-Cermeno JC. Increased levels of plasma von Willebrand factor in migraine crisis. Acta Neurol Scand 1995 91 : 412 3.
86. Gallai V, Sarchielli P, Firenze C, Trequattrini A, Paciaroni M, Usai F et al. Endothelin 1 in migraine and tension-type headache. Acta Neurol Scand 1994 89 : 47 55.
87. Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 2006 46 : 200 7.
88. Leira R, Sobrino T, Rodriguez-Yanez M, Blanco M, Arias S, Castillo J. Mmp-9 immunoreactivity in acute migraine. Headache 2007 47 : 698 702.
89. Dreier JP, Kleeberg J, Petzold G, Priller J, Windmuller O, Orzechowski HD et al. Endothelin-1 potently induces Leao's cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura? Brain 2002 125 : 102 12.
90. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005 64 : 614 20.
91. Bushnell CD, Jamison M, James AH. Migraines during pregnancy are associated with stroke and vascular diseases: data from the nationwide inpatient sample. Neurology 2007 68 (Suppl. 1 A130 (Abstract).
92. Lisi V, Garbo G, Battistella P, Micciche F, Stecca A, Terrazzino S et al. Endothelin receptor A -231 G>A polymorphism: no linkage to primary pediatric headache. Headache 2006 46 : 486 91.
93. Gobron C, Vahedi K, Vicaut E, Stucker O, Laemmel E, Baudry N et al. Characteristic features of in vivo skin microvascular reactivity in CADASIL. J Cereb Blood Flow Metab 2007 27 : 250 7.
94. Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet 1995 346 : 934 9.
95. Ito A, Egashira K, Narishige T, Muramatsu K, Takeshita A. Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension. Jpn Circ J 2001 65 : 775 8.
96. Markley HG. Verapamil and migraine prophylaxis: mechanisms and efficacy. Am J Med 1991 90 (5A 48S 53S.
97. Schrader H, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ 2001 322 : 19 22.
98. Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 2003 289 : 65 9.